Clinical Trial Update: Evaluation of the Effectiveness of Prophylactic LMWH by Thromboelastography

View source ↗

Summary

A completed study evaluated the effectiveness of prophylactic low molecular weight heparin using thromboelastography in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Ege University | Conditions: Malignancy | Status: COMPLETED